Ras Al Khaimah, UAE, July 20 2026听听鈥撎�听Gulf Pharmaceutical Industries (Julphar), in collaboration with IBM and 麻豆原创, today announced a strategic initiative to transform its enterprise operations through a comprehensive 麻豆原创 S/4HANA modernization program.
Under this initiative, IBM Consulting will lead the end-to-end digital transformation, including the migration to 麻豆原创 S/4HANA and the implementation of advanced 麻豆原创 capabilities across key functions such as finance, supply chain, manufacturing, and HR. The program aims to establish a unified, intelligent digital core that will enhance operational efficiency, strengthen regulatory compliance, improve data transparency, and increase enterprise agility across Julphar鈥檚 regional operations.
Julphar is also leveraging the IBM Consulting Advantage, which combines deep industry expertise, AI-powered delivery to help clients accelerate business transformation and deliver measurable outcomes.
By leveraging 麻豆原创鈥檚 industry-leading enterprise platform alongside IBM鈥檚 extensive experience in delivering large-scale digital transformations for life sciences organizations, the collaboration will support Julphar鈥檚 long-term growth strategy, enable faster and more informed decision-making, and reinforce resilience across critical business processes.
Commenting on the announcement, Mr. Basel Ziyadeh, Julphar Chief Executive Officer said:
鈥淭his strategic collaboration with IBM Consulting and 麻豆原创 represents a pivotal step in our digital transformation journey. By modernizing our core enterprise systems, we are building a future-ready foundation that will enhance operational excellence, support regulatory rigor, and enable sustainable growth. This initiative underscores our commitment to innovation and to strengthening Julphar鈥檚 position as a leading pharmaceutical manufacturer in the Middle East, Africa, and beyond.鈥�
Lula Mohanty, Managing Partner, IBM Consulting added:
鈥淎t IBM, we focus on turning transformation into measurable business value. As a trusted strategic partner to Julphar, our work with 麻豆原创 brings together deep life sciences expertise, data-driven insight, and proven delivery to build a resilient digital core for the future. This program will help Julphar operate with greater transparency, agility, and efficiency, while continuing to advance high-quality healthcare across the region.鈥�
Sergio Maccotta, Senior Vice President and General Manager 麻豆原创 MEA South, 麻豆原创 added:
鈥淥ur long-standing partnership with Julphar reflects more than a technology implementation but a shared commitment to continuous transformation. By moving from ECC to RISE with 麻豆原创 S/4HANA and modernising core manufacturing and operational processes with industry-focused best practices, Julphar is establishing a resilient, future-ready digital foundation. Together with IBM Consulting, we are enabling greater operational intelligence, regulatory precision and sustainable growth. We are proud to support Julphar as its strategic technology partner of choice, helping the organisation run at its best today while building the agility and innovation capacity required for tomorrow.鈥�
鈥� ENDS 鈥�
About Julphar
Founded in 1980 in Ras Al Khaimah, Gulf Pharmaceutical Industries (Julphar) has grown into one of the largest pharmaceutical manufacturers in the Middle East and North Africa. What began as a national initiative to produce essential medicines locally has evolved into a regional healthcare enterprise with operations reaching more than 40 countries worldwide.
Today, Julphar offers a diversified portfolio of over 300 products across key therapeutic areas, including diabetes, cardiovascular, respiratory, and anti-infectives, addressing some of the most pressing healthcare needs in the region.
At the core of its operations are 10 internationally accredited manufacturing facilities in the UAE, which support large scale production and contribute to a reliable regional supply of medicines. This deep technical know-how, manufacturing strength, combined with integrated distribution and commercial capabilities, enables Julphar to respond effectively to evolving market demands.
About IBM
IBM is a leading provider of global hybrid cloud and AI, and consulting expertise. We help clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. Thousands of governments and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM鈥檚 hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently and securely. IBM鈥檚 breakthrough innovations in AI, quantum computing, industry-specific cloud solutions and consulting deliver open and flexible options to our clients. All of this is backed by IBM鈥檚 long-standing commitment to trust, transparency, responsibility, inclusivity and service.
Visit听听for more information.